ECM1 and ovarian cancer: In these dysfunctional ORGs, combined with relevant researches, ABCG1 is a potential target for treating ovarian cancer associated with ECM1-activated signaling [35], while LEPR is the one of breast cancer risk factors [36], indicating ORGs might play important roles in PRAD.